Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
The Role of Pharmacy Personnel in Assisting Medicare Beneficiaries with Limited Income and Resources
- ADSS Certified Aging Resource Educated Specialists (C.A.R.E.S.)
- 3.00 ACPE Pharmacy
- 3.00 ACPE Technician
$0.00
The C.A.R.E.S. continuing education programs are designed for Alabama pharmacists and pharmacy technicians to provide an overview of Medicare and the roles of the Aging and Disability Resource Centers (ADRCs) with the primary goal to help pharmacists and pharmacy staff effectively and efficiently assist Medicare beneficiaries. All of our CE programs are funded by the Alabama Department of Senior Services (ADSS) and the U.S. Administration for Community Living. They are made available to pharmacists and technicians in Alabama at no cost.
- Live @ Lunch
$100.00
You are currently registering for LIVE @ LUNCH Series Subscription program. There are five 1-hour courses included in the webinar series and each can be purchased separately. This subscription enrollment will provide a code to access any/all of the 5 Live at Lunch webinars. Live programs will be recorded and posted for non-live credit. Series subscribers that are unable to attend the live program can be enrolled in the non-live program for no additional cost. LIVE @ LUNCH subscription for $100 includes:
- Alabama Community Engagement Alliance against COVID-19 Disparities (Alabama CEAL)
- 1.20 ABN
- 1.00 ACPE Pharmacy
$0.00
- Live @ Lunch
- 1.20 ABN
- 1.00 ACPE Pharmacy
$25.00
LIVE @ LUNCH - HFpEF: Time for a Deeper Look webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for all 2024 Live @ Lunch webinars.
- On-Demand
- 1.00 ACPE Pharmacy
$25.00
Family planning and contraceptive care have recently been debated within the state of Alabama . The Supreme Court of Alabama's February ruling that cryogenic IVF embryos be recognized as children and entitled to legal protection has resulted in bills proposing civil and criminal immunity for IVF facilities (S 159) and protecting access to contraceptive care (HB 279).
- Live @ Lunch
- 1.00 ACPE Pharmacy
$25.00
LIVE @ LUNCH - Push" for Weight Loss: Updates on pharmacotherapy for weight loss webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for all 2024 Live @ Lunch webinars.
- On-Demand
- 1.00 ACPE Pharmacy
$25.00
This presentation will provide attendees with an update on key changes in COPD over the past 5 years.
- On-Demand
- 1.00 ACPE Pharmacy
- 1.00 ACPE Technician
$25.00
This presentation will describe the basics of Medicare and Medicaid, financial assistance programs for older adults, and how to protect older adults from Medicare fraud.
- On-Demand
- 1.00 ACPE Pharmacy
$25.00
This presentation will cover the essentials of drug interactions (recognize, evaluate, mitigate) with specific focus on drug-drug and drug disease interactions in older adults (i.e. 65 years of age or older). Older adults are more likely than younger adults to take numerous concomitant medications and have multiple comorbidities, increasing their risk of drug interactions and subsequent adverse drug events.
- On-Demand
- 1.20 ABN
- 1.00 ACPE Pharmacy
$25.00
Chronic coronary disease (CCD), formerly known as "stable ischemic heart disease," encompasses a diverse range of conditions, including both obstructive and nonobstructive coronary artery disease (CAD), with or without a history of myocardial infarction (MI) or revascularization. It also includes ischemic heart disease diagnosed solely through noninvasive testing and chronic angina syndromes arising from various underlying causes. Approximately 20 million people in the United States live with CCD, and it remains a leading cause of death.